ArticleRespirology case reports2026
Autoimmune-Associated Pulmonary Inflammatory Myofibroblastic Tumour: A Diagnostic and Therapeutic Challenge.
Article in Respirology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Autoimmune-Associated Pulmonary Inflammatory Myofibroblastic Tumour: A Diagnostic and Therapeutic Challenge.Respirology case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary inflammatory myofibroblastic tumour (IMT) is a rare mesenchymal neoplasm with variable biological behaviour, ranging from benign inflammatory lesions to locally aggressive tumours. Its association with autoimmune phenomena remains unclear. We report a woman in her twenties with a prior diagnosis of lung IMT who re-presented with chronic respiratory symptoms, systemic features and radiological progression. Repeat evaluation revealed bilateral bronchocentric consolidation, positive antinuclear antibodies and histopathological findings consistent with fibro-inflammatory disease, without ALK expression or significant IgG4 infiltration. Concomitant erythema nodosum supported an autoimmune process. Repeat biopsy did not fully reproduce the original IMT morphology, and follow-up remains limited. She had significant clinical, functional and radiological improvement following immunosuppressive therapy. This case emphasizes the diagnostic complexity of lung masses in young patients and emphasizes the importance of considering autoimmune-associated IMT as a potentially reversible condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.